Mayo Clinic News Network

News Resources

Items tagged as "Stephen Ansell"

Ansell what is PD1 (:37)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Ansell describes NHL and patients (:34)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Ansell describes clinical trial (:30)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Ansell take away and future research (:37)

Stephen Ansell, M.D., Ph.D., a Mayo Clinic hematologist, describes the results of a phase I clinical trial of nivolumab for Hodgkin's lymphoma.

Created by Brian Kilen

Mayo Clinic: Exhaustion Renders Immune Cells Less Effective in Cancer Treatment

Mayo Clinic: Exhaustion Renders Immune Cells Less Effective in Cancer Treatment

ROCHESTER, Minn. — May 9, 2012.  Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic study has found. The findings appear in the Journal of Clinical Investigation. The study [...]

Created by Joe Dangor